Paper42007396
Peptide-Based Therapeutics for Alzheimer's Disease: Medicinal Chemistry, AI-Guided Computational Design, and Blood-Brain Barrier Delivery.
Al Khzem AH and 1 other. Drug Des Devel Ther, 2026. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Peptide-Based Therapeutics for Alzheimer's Disease: Medicinal Chemistry, AI-Guided Computational Design, and Blood-Brain Barrier Delivery. Papers, record 42007396. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42007396
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Peptide-Based Therapeutics for Alzheimer's Disease: Medicinal Chemistry, AI-Guided Computational Design, and Blood-Brain Barrier Delivery.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Design | Major topic |
| Blood-Brain Barrier | Major topic |
| Drug Delivery Systems | Major topic |
| Alzheimer Disease | Major topic |
| Peptides | Major topic |
| Chemistry, Pharmaceutical | |
| Artificial Intelligence | |
| Humans | |
| Disease Models, Animal | |
| Animals |
Source PubMed
References161
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34959346 | Protease-Resistant Peptides for Targeting and Intracellular Delivery of Therapeutics. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34959346 | PubMed |
| 2 | 39877373 | Mitochondrial dysfunction in Alzheimer's disease: a key frontier for future targeted therapies. | Front Immunol | 2024 | https://conductscience.org/library/papers/39877373 | PubMed |
| 3 | 39074563 | Emerging role of Metformin in Alzheimer's disease: A translational view. | Ageing Res Rev | 2024 | https://conductscience.org/library/papers/39074563 | PubMed |
| 4 | 22236121 | Peptides for therapy and diagnosis of Alzheimer's disease. | Curr Pharm Des | 2012 | https://conductscience.org/library/papers/22236121 | PubMed |
| 5 | 39997662 | Topic Issue: "Translational Advances in Neurodegenerative Dementias". | Neurol Int | 2025 | https://conductscience.org/library/papers/39997662 | PubMed |
| 6 | 29186912 | Computer-Aided Drug Design Applied to Marine Drug Discovery: Meridianins as Alzheimer's Disease Therapeutic Agents. | Mar Drugs | 2017 | https://conductscience.org/library/papers/29186912 | PubMed |
| 7 | 40732273 | From Lab to Clinic: How Artificial Intelligence (AI) Is Reshaping Drug Discovery Timelines and Industry Outcomes. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40732273 | PubMed |
| 8 | 35298810 | Dynamics of Amyloid Formation from Simplified Representation to Atomistic Simulations. | Methods Mol Biol | 2022 | https://conductscience.org/library/papers/35298810 | PubMed |
| 9 | 39653296 | Peptide-based inhibitors and nanoparticles: Emerging therapeutics for Alzheimer's disease. | Int J Pharm | 2025 | https://conductscience.org/library/papers/39653296 | PubMed |
| 10 | 39814713 | Illuminating the impact of N-terminal acetylation: from protein to physiology. | Nat Commun | 2025 | https://conductscience.org/library/papers/39814713 | PubMed |
| 11 | 30895453 | PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution. | Drug Deliv Transl Res | 2019 | https://conductscience.org/library/papers/30895453 | PubMed |
| 12 | 31879928 | Peptidomimetic Synthesis: Drug Discovery for Alzheimer's Disease. | Methods Mol Biol | 2020 | https://conductscience.org/library/papers/31879928 | PubMed |
| 13 | 23428883 | Approaches for enhancing oral bioavailability of peptides and proteins. | Int J Pharm | 2013 | https://conductscience.org/library/papers/23428883 | PubMed |
| 14 | 25225492 | Systems-Level G Protein-Coupled Receptor Therapy Across a Neurodegenerative Continuum by the GLP-1 Receptor System. | Front Endocrinol (Lausanne) | 2014 | https://conductscience.org/library/papers/25225492 | PubMed |
| 15 | 23173066 | The role of molecular simulations in the development of inhibitors of amyloid β-peptide aggregation for the treatment of Alzheimer's disease. | ACS Chem Neurosci | 2012 | https://conductscience.org/library/papers/23173066 | PubMed |
| 16 | 40494420 | Fighting Alzheimer's naturally: Peptides as multitarget drug leads. | Bioorg Med Chem Lett | 2025 | https://conductscience.org/library/papers/40494420 | PubMed |
| 17 | 39560122 | Recent advances in peptide macrocyclization strategies. | Chem Soc Rev | 2024 | https://conductscience.org/library/papers/39560122 | PubMed |
| 18 | 32695874 | Alzheimer's disease drug development pipeline: 2020. | Alzheimers Dement (N Y) | 2020 | https://conductscience.org/library/papers/32695874 | PubMed |
| 19 | 31742308 | Real-time monitoring of solid-phase peptide synthesis using a variable bed flow reactor. | Chem Commun (Camb) | 2019 | https://conductscience.org/library/papers/31742308 | PubMed |
| 20 | 37002811 | Peptides for trans-blood-brain barrier delivery. | J Labelled Comp Radiopharm | 2023 | https://conductscience.org/library/papers/37002811 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| GLP1R | 2740 | PubTator's text mining | https://conductscience.org/library/genes/2740 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
| OXT | 5020 | PubTator's text mining | https://conductscience.org/library/genes/5020 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42007396
GET https://conductscience.org/api/papers/v1/42007396/references?page=2